ROCKVILLE, Md., Oct. 23, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that Cytomedix Chairman and Chief Executive Officer Dr. Kshitij Mohan will present an overview of the Company to financial analysts and leading healthcare scientists at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, on Tuesday, Nov. 6, 2007 at 9:10 a.m. eastern time. The conference will be held at the New York Palace Hotel in New York City.
During the 20 minute presentation, Dr. Mohan will provide an overview of the Company and discuss its goals and outlook for the future. A Webcast of the presentation will be available live and for 90 days after the conference at http://www.wsw.com/webcast/rrshq12/gtf or on the Company's website at www.cytomedix.com. For more information or to register for the conference, please visit http://www.rodmanandrenshaw.com/conferences?id=6
ABOUT CYTOMEDIX
Cytomedix, Inc. is a biotechnology company specializing in processes and products derived from autologous platelet releasates for uses in the treatment of wounds and other applications. The current offering is AutoloGel(tm), an FDA cleared treatment that utilizes an autologous platelet gel composed of multiple growth factors, other platelet releasates, and fibrin matrix. The Company has announced favorable results from its blinded, prospective, multi-center clinical trial on the use of its technology in healing diabetic foot. Additional information regarding Cytomedix is available at: http://www.cytomedix.com